State Of New Jersey Common Pension Fund D Avadel Pharmaceuticals PLC Transaction History

State Of New Jersey Common Pension Fund D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 23, 2019	SELL	$1.92 - $4.47 $23,913 - $55,673	-12,455 Closed	0 $0
Q2 2019 Jul 22, 2019	SELL	$1.09 - $3.19 $1,701 - $4,979	-1,561 Reduced 11.14%	12,455 $36,000
Q3 2018 Oct 15, 2018	SELL	$4.08 - $7.14 $114,541 - $200,448	-28,074 Reduced 66.7%	14,016 $62,000
Q3 2017 Oct 25, 2017	BUY	$8.35 - $10.5 $351,451 - $441,945	42,090	42,090 $442,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.